Biomarin Pharmaceutical Inc (BMRN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Biomarin Pharmaceutical Inc-Aktie (BMRN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.41% 648.83	646.21	581.33	595.27	596.41
Cost Of Revenue	7.60% 125.18	135.48	124.75	128.08	126.55
Gross Profit	2.53% 523.65	510.73	456.58	467.19	469.87
Operating Expenses	12.35% 435.19	496.51	430.92	408.32	410.52
Interest Income/Expense	41.83% 3.547	6.098	3.779	3.755	3.703
Benefits Costs and Expenses	13.33% 543.29	626.88	539.66	524.47	539.66
Costs And Expenses	11.33% 560.37	631.99	555.67	536.40	537.07
Operating Income/Loss	522.14% 88.46	14.22	25.66	58.87	59.35
Income/Loss From Continuing Operations Before Tax	446.11% 105.55	19.33	41.67	70.81	56.76
Income Tax Expense/Benefit, Deferred	101.15% 0.285	-24.84	-15.03	1.252	-6.36
Income Tax Expense/Benefit	1,711% 16.89	-1.048	1.291	14.77	5.905
Income/Loss From Continuing Operations After Tax	335.15% 88.66	20.38	40.38	56.04	50.85
Net Income/Loss	335.15% 88.66	20.38	40.38	56.04	50.85
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	86,935% 188.87	0.217	188.22	187.95	186.67
Diluted Average Shares	5,881% 199.26	-3.447	191.17	195.00	194.36
Basic Earnings Per Share	327.27% 0.47	0.11	0.21	0.30	0.27
Diluted Earnings Per Share	360.00% 0.46	0.10	0.21	0.29	0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$77.28

2.02%

SMMT

$20.39

2.15%

UTHR

$382.77

1.58%

MRNA

$53.29

0.47%

BGNE

$208.03

0.38%

BNTX

$110.97

1.84%